{"task_id": "06cfa55411862c68", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 215/464)", "text": "OLOGY (CONT\u2019D)\n204\nCancer of the Exocrine Pancreas\n\n--- Page 226 ---\nSTAGING (CONT\u2019D)\nN stage (portal, peripancreatic, periaortic, celiac\naxis LN)\n\u0002 N1=regional LN\nM stage (liver, lungs, bone, pleura, adrenal)\n\u0002 M1=distant metastasis\nSTAGE GROUPINGS\nStage\nTNM @=any\nFreq.\nMedian\nsurvival\n(months)\nIA\nT1N0M0\nIB\nT2N0M0 g\n10%\n17\nIIA\nT3N0M0\nIIB\nT1 3N1M0g\n20 30%\n8 9\nIII\nT4N@M0\nIV\nT@N@M1\n50 60%\n4 6\nINVESTIGATIONS\nBASIC\n\u0002\nLABS\nCBCD, lytes, urea, Cr, AST, ALT, ALP, bilir\nubin, INR, PTT, albumin, lipase, CA 19 9, CEA\n\u0002\nIMAGING\nCXR, CT abd (allows for establishment\nof resectability criteria, >90% accurate in the\nstaging), U/S abd, endoscopic U/S, MRCP\n\u0002\nBIOPSY\npercutaneous needle biopsy (only if\nunresectable disease), endoscopic U/S guided\nbiopsy, ERCP (also useful for biliary obstruction),\nlaparoscopy, laparotomy\nDIAGNOSTIC ISSUES\nCT FINDINGS FOR PANCREATIC CANCER\nmass\n(identified in 96% of cases), dilatation of the bile\nand pancreatic ducts (double duct sign) suggests a\npancreatic head lesion, dilatation of the pancreatic\nduct proximal to the tumor, atrophy of the pancreas\ndistal to a tumor\nMANAGEMENT\nRESECTABLE (T1 3N0 1, 10 20%)\nWhipple\u2019s pro\ncedure plus either adjuvant chemotherapy (gemci\ntabine or 5 fluorouracil) or adjuvant chemoradiation\n(5 fluorouracil) \u0006 gemcitabine in selected patients\nNON RESECTABLE (locally advanced and metastatic\ndisease)\n\u0002\nPALLIATIVE CHEMOTHERAPY\ngemcitabine \u0006 erlotinib.\nNo standard in second line. Consider 5 fluorouracil\nbased therapy\n\u0002\nCHEMORADIATION\n(5 fluorouracil)\nin\nselected\npatients with limited advanced unresectable\ncancer\n\u0002\nPAIN CONTROL\nopioids, percutaneous celiac gang\nlion ablation\n\u0002\nPALLIATIVE RADIATION\ncontroversial with no clear\nbenefit\n\u0002\nPALLIATIVE PROCEDURES\nif biliary obstruction, con\nsider ERCP stent placement or percutaneous trans\nhepatic cholangiography with drainage\nTREATMENT ISSUES\nRESECTABLE DISEASE CRITERIAa\n1. No liver, peritoneal, or other metastases\n2. No involvement of celiac axis, superior mesenteric\nartery, and hepatic artery\n3. No encasement of portal vein and superior mesen\nteric vein (adherence of the tumor to a segment of\nthese veins may allow resection with venous\nreconstruction)\naIf in doubt, patients should be evaluated by a hepa\ntobiliary surgeon\nRelated Topics\nCachexia (p. 397)\nCancer Pain (p. 391)\nJaundice (p. 138)\nHepatocellular Carcinoma\nDIFFERENTIAL DIAGNOSIS OF FOCAL LIVER LESION\n(BY ULTRASOUND)\nSOLID LESION\n\u0002\nHYPOECHOIC\nmalignant (hepatocellular carci\nnoma,\nmetastasis),\nbenign\n(focal\nnodular\nhyperplasia, hepatic adenoma, hamartoma)\n\u0002\nHYPERECHOIC\nhemangioma, calcification, focal fat\nCYSTIC LESION\n\u0002\nSIMPLE\nbenign\n\u0002\nCOMPLEX\nbleeding, infections, Echinococcus\nPATHOPHYSIOLOGY\nRISK FACTORS\nany causes of cirrhosis, particularly\nHBV, HCV, alcohol, and hemochromatosis. Note that\nHBV may cause hepatocellular carcinoma without\ncirrhosis as the virus can integrate into host genome.\nEnvironmental toxins include aflatoxin, the blue\ngreen algal toxin Microcystin, and betelnut chewing\nCLINICAL FEATURES\nLOCOREGIONAL\nupper abdominal pain, early sati\nety, obstructive jaundice, intra abdominal bleeding\ndue to tumor rupture, decompensation of liver\nHepatocellular Carcinoma\n205", "text_length": 3177, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 215/464)", "type": "chunk", "chunk_index": 214, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.542266", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.543047", "status": "complete", "chunks_added": 2}